Key terms

About ABCL

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ABCL news

Apr 17 4:55am ET AbCellera management to meet with Truist by TipRanks Apr 15 7:50am ET AbCellera management to meet with Truist by TipRanks Mar 11 9:14am ET AbCellera gets upfront payment for collaboration with Biogen for antibodies by TipRanks Feb 24 10:11am ET Peter Thiel Retires from AbCellera Board, Dr. Andrew Lo Steps In by TipRanks Feb 23 7:33am ET Piper Sandler Reaffirms Their Buy Rating on AbCellera Biologics (ABCL) by TipRanks Feb 22 6:59am ET AbCellera upgraded to Buy at Benchmark after R&D progress by TipRanks Feb 22 6:17am ET AbCellera upgraded to Buy from Hold at Benchmark by TipRanks Feb 22 12:16am ET AbCellera Biologics: A Strong Buy on Robust Pipeline and Solid Financial Outlook by TipRanks Feb 21 8:23am ET AbCellera price target lowered to $17 from $21 at Stifel by TipRanks Feb 21 8:14am ET Stifel Nicolaus Reaffirms Their Buy Rating on AbCellera Biologics (ABCL) by TipRanks Feb 21 7:31am ET Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Teladoc (TDOC) and Alnylam Pharma (ALNY) by TipRanks Feb 20 9:30pm ET Analysts Offer Insights on Healthcare Companies: Halozyme (HALO) and AbCellera Biologics (ABCL) by TipRanks Feb 20 4:47pm ET AbCellera Biologics Reviews 2023 Financial Performance by TipRanks Feb 20 4:07pm ET AbCellera reports FY23 EPS (51c), consensus (47c) by TipRanks

No recent press releases are available for ABCL

ABCL Financials

1-year income & revenue

Key terms

ABCL Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ABCL Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming